Ganglio centinela en melanoma maligno cutáneo de tronco y extremidades. Experiencia en el Instituto Nacional de Cancerología, Bogotá, Colombia, 2000-2007

Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007; 57:43-66.

https://doi.org/10.3322/canjclin.57.1.43

República de Colombia. Instituto Nacional de Cancerología (INC). Registro institucional de cáncer: anuario estadístico 2006. Bogotá, INC; 2007.

República de Colombia. Instituto Nacional de Cancerología (INC). Registro institucional de cáncer: anuario estadístico 2007. Bogotá: INC; 2008.

República de Colombia. Instituto Nacional de Cancerología (INC). Registro institucional de cáncer: anuario estadístico 2008. Bogotá: INC; 2009.

Balch C, Soong S, Gershenwald JE, et al. Prognostic factor analysis of 17600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622-34.

https://doi.org/10.1200/JCO.2001.19.16.3622

Milton GW, Shaw HH, Mc Carthy WJ, et al. Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg. 1982;69:108-11.

https://doi.org/10.1002/bjs.1800690217

Sim FH, Taylor WF, Ivins JC, et al. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Cancer. 1978;41:948-56.

https://doi.org/10.1002/1097-0142(197803)41:3<948::AID-CNCR2820410324>3.0.CO;2-Z

Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection of stage I melanoma of the limbs. N Eng J Med. 1977;297:627-30.

https://doi.org/10.1056/NEJM197709222971202

Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer. 1982;49:2420-30.

https://doi.org/10.1002/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2

Morton DL, Wanek L, Nizze J, et al. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg. 1991;214:491-501.

https://doi.org/10.1097/00000658-199110000-00013

Sim FH, Taylor WF, Pritchard DJ, et al. Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study. Mayo Clin Proc. 1986;61:697-705.

https://doi.org/10.1016/S0025-6196(12)62768-2

Cascinelli N, Morabito A, Santinami M, et al. Inmediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial, WHO Melanoma Programme. Lancet. 1998;351:793-6.

https://doi.org/10.1016/S0140-6736(97)08260-3

Balch DM, Soong S, Ross MI, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanoma (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol. 2000;7:87-97.

https://doi.org/10.1007/s10434-000-0087-9

Morton DL, Thompson JF, Cochran AJ, et al. Sentinelnode biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-17.

https://doi.org/10.1056/NEJMoa060992

Morton DL, Cochran AJ. The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma. Br J Dermatol. 2004;151:308-19.

https://doi.org/10.1111/j.1365-2133.2004.06133.x

Morton DL. Sentinel lymphadenectomy for patients with clinical stage I melanoma. J Surg Oncol. 1997;66:267-9.

https://doi.org/10.1002/(SICI)1096-9098(199712)66:4<267::AID-JSO9>3.0.CO;2-9

Piris A, Mihm MC. Progress in melanoma histopathology and diagnosis. Hematol Oncol Clin N Am. 2009;23:467-80.

https://doi.org/10.1016/j.hoc.2009.03.012

Balch CM, Soong S, Atkins MB, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin. 2004;54:131-49.

https://doi.org/10.3322/canjclin.54.3.131

McMasters KM, Noyes RD, Reintgen DS, et al. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol. 2004; 86:212-23.

https://doi.org/10.1002/jso.20084

República de Colombia.Instituto Nacional de Cancerología (INC). Melanoma: guía de práctica clínica en enfermedades neoplásicas. Bogotá: INC; 2001.

Seaman W, Powers WE. Studies on the distribution of radioactive colloidal gold in regional lymph nodes containing cancer. Cancer. 1995;8:1044-6.

https://doi.org/10.1002/1097-0142(1955)8:5<1044::AID-CNCR2820080530>3.0.CO;2-6

Gould EA, Winship T, Philbin PH, et al. Observations on a sentinel node in cancer of the parotid. Cancer. 1960;13:77-8.

https://doi.org/10.1002/1097-0142(196001/02)13:1<77::AID-CNCR2820130114>3.0.CO;2-D

Cabañas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456-66.

https://doi.org/10.1002/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO;2-I

Thompson JF, Niewind P, Uren RF, et al. Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients. Melanoma Res. 1997;7:500-6.

https://doi.org/10.1097/00008390-199712000-00009

Rousseau DL Jr, Ross MI, Johnson MM, et al. Revised American Joint Committee on Cancer stanging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol. 2003;10:569-74.

https://doi.org/10.1245/ASO.2003.09.016

Lee JH, Essner R, Torisu-Itakura H, et al. Factors predictive of tumor-positive nonsentinel lymph nodes after tumorpositive sentinel lymph node dissection for melanoma. J Clin Oncol. 2004;22:3677-84.

https://doi.org/10.1200/JCO.2004.01.012

Cochran AJ, Wen DR, Huang RR, et al. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcomes based on the primary melanoma and the sentinel node. Mod Pathol. 2004;17:747-55.

https://doi.org/10.1038/modpathol.3800117

Morton D, Cochran A, Thompson J, et al. Sentinel Node Biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an International Multicenter Trial. Ann Surg. 2005;242:302-13.

https://doi.org/10.1097/01.sla.0000181092.50141.fa

Hettiaratchy SP, Kange N, O'Tootle G, et al. Sentinel lymph node biopsy in malignant melanoma: a series of 100 consecutive patients. Br J Plast Surg. 2000;53:559-662.

https://doi.org/10.1054/bjps.2000.3409

Sabel MS, Griffith KA, Arora A, et al. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery. 2007;141:728-35.

https://doi.org/10.1016/j.surg.2006.12.018

Morton D, Cochran A, Thompson J, Elashoff R, Essner R, Glass EC, et al. Sentinel Node Biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an International Multicenter Trial. Ann Surg 2005; 242: 302-313.

https://doi.org/10.1097/01.sla.0000181092.50141.fa

Rughani MG, Swan MC, Adams TS, Middleton MR, Ramcharan RN, Pay A, et al. Sentinel lymph node biopsy in melanoma: the Oxford ten year clinical experience. J Plast Reconstr Aesthet Surg 2011: 64 (10): 1284-1290.

https://doi.org/10.1016/j.bjps.2011.05.001

Satzger I, Meier A, Hoy L, Völker B, Kapp A, Hauschild A, et al. Sentinel node dissection delays recurrence and prolongs melanoma-related survival: an analysis of 673 patients from a single center with long-term follow-up: Ann Surg Oncol 2011; 18: 514-520.

https://doi.org/10.1245/s10434-010-1318-3

Balch CM, Soong S, Ross MI, Urist MM, Karakousis CP, Temple WJ et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000; 7:87-97.

https://doi.org/10.1007/s10434-000-0087-9

Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000; 7:469-474.

https://doi.org/10.1007/s10434-000-0469-z